Atrial fibrillation imposes a substantial economic burden in the United States, with estimated national incremental costs ranging from $6.0 to $26.0 billion.
On the basis of current US age- and sex-specific prevalence data, the national incremental AF cost is estimated to range from $6.0 to $26.0 billion.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: